World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
58
Citations
17653
World Ranking
3369
National Ranking
1328

Overview

Rajesh T. Gandhi is affiliated with Harvard University in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in Infectious Diseases, Virology, Epidemiology, Emergency Medicine, and Neurology.

The scientist's work covers several main topics, including:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • COVID-19 Clinical Research Studies
  • HIV/AIDS drug development and treatment
  • SARS-CoV-2 and COVID-19 Research
  • HIV-related health complications and treatments
  • Long-Term Effects of COVID-19

Rajesh T. Gandhi has published numerous papers, some of the recent and notable ones include:

  • "Mild or Moderate Covid-19," 2020, New England Journal of Medicine
  • "Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults," 2022, JAMA

The scientist frequently collaborates with several co-authors, including:

  • Ronald J. Bosch
  • Joseph J. Eron
  • John W. Mellors
  • Deborah K. McMahon
  • Joshua C. Cyktor

Their research has appeared in a variety of publication venues, with the most frequent being:

  • Journal watch
  • UNC Libraries
  • Clinical Infectious Diseases
  • The Journal of Infectious Diseases
  • JAMA

Best Publications

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

    George B Cohen;George B Cohen;Rajesh T Gandhi;Daniel M Davis;Ofer Mandelboim

  • Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.

    Adarsh Bhimraj;Rebecca L. Morgan;Amy Hirsch Shumaker;Valery Lavergne

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F. Günthard;Michael S. Saag;Constance A. Benson;Carlos del Rio

  • Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors.

    Eric A. Meyerowitz;Aaron Richterman;Rajesh T. Gandhi;Paul E. Sax

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

    Michael S. Saag;Constance A. Benson;Rajesh T. Gandhi;Jennifer F. Hoy

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.

    Unknown

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.

    Michael S. Saag;Rajesh T. Gandhi;Jennifer F. Hoy;Raphael J. Landovitz

  • CD8 Epitope Escape and Reversion in Acute HCV Infection

    Joerg Timm;Georg M. Lauer;Daniel G. Kavanagh;Isabelle Sheridan

  • The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

    Rajesh T. Gandhi;Lu Zheng;Ronald J. Bosch;Ellen S. Chan

  • Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection

    Cheryl L. Day;Georg M. Lauer;Gregory K. Robbins;Barbara McGovern;Barbara McGovern

  • The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption

    Jonathan Z. Li;Behzad Etemad;Hayat Ahmed;Evgenia Aga

  • CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef.

    B K Chen;R T Gandhi;D Baltimore

  • Update on Human Immunodeficiency Virus (HIV)-2 Infection

    Omobolaji T. Campbell-Yesufu;Rajesh T. Gandhi;Rajesh T. Gandhi

  • Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384

    Gregory K. Robbins;John G. Spritzler;Ellen S. Chan;David M. Asmuth

  • HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy

    Guillaume J. Besson;Christina M. Lalama;Ronald J. Bosch;Rajesh T. Gandhi

  • HIV-1 Directly Kills CD4+ T Cells by a Fas-independent Mechanism

    Rajesh T. Gandhi;Benjamin K. Chen;Stephen E. Straus;Janet K. Dale

  • Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.

    Rajesh T. Gandhi;John Spritzler;Ellen Chan;David M. Asmuth

  • Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.

    Rajesh T. Gandhi;Deborah K. McMahon;Ronald J. Bosch;Christina M. Lalama

  • Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.

    Barbara H. McGovern;Barbara H. McGovern;Jeremy S. Ditelberg;Jeremy S. Ditelberg;Lynn E. Taylor;Lynn E. Taylor;Rajesh T. Gandhi

  • Clinical Characteristics of 2019 Novel Coronavirus Infection

    Rajesh T. Gandhi

  • CTL epitope escape and reversion in acute HCV infection.

    J Timm;G Lauer;D Kavanagh;A Kim

Frequent Co-Authors

Ronald J. Bosch
Ronald J. Bosch Harvard University
John W. Mellors
John W. Mellors University of Pittsburgh
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Bruce D. Walker
Bruce D. Walker Harvard University
Jonathan Z. Li
Jonathan Z. Li Brigham and Women's Hospital
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Paul E. Sax
Paul E. Sax Brigham and Women's Hospital
Arthur Y. Kim
Arthur Y. Kim Harvard University
Nina Bhardwaj
Nina Bhardwaj Icahn School of Medicine at Mount Sinai
Steven G. Deeks
Steven G. Deeks University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to a variety of related online degrees and career paths, some of which may not be immediately obvious. For those with unique challenges, finding online colleges that accept felons can provide valuable opportunities for higher education and career advancement in the health sciences.

One growing career option is becoming a functional medicine nurse practitioner. This role blends traditional nursing with a focus on holistic and integrative medical treatments, often drawing on microbiology knowledge related to the body’s complex systems.

Beyond clinical roles, the healthcare industry also values positions like certified professional coders, who manage patient data for billing and compliance. Understanding the path to becoming a CPC can be a smart move for microbiology graduates interested in the administrative side of healthcare.

Similarly, careers in health information management are essential for organizing clinical data and improving patient outcomes. Learning about the health information manager salary and career paths can guide students toward well-paid roles that support medical research and care delivery.

Best Scientists Citing Rajesh T. Gandhi

Trending Scientists